Ind-Swift Laboratories Ltd.
INDSWFTLAB Share PricePharmaceuticals & Drugs
₹93.18
-1.6 (-1.7%)
As on December 4, 2025
Exchange Scrips: BSE532305NSEINDSWFTLABISININE915B01019
Market Cap ₹ 761 Cr
P/E Ratio 2.56
Dividend Yield N/A
Performance
Market performance
Open94.3
High94.36
Volumes37,155
Prev93.18
Low92.96
As on2025-12-04
Historical performance
1 Year High124
3 Year High186
5 Year High186
1 Year Low68.72
3 Year Low53.95
5 Year Low52.65
Fundamentals
Company Valuation
Market Cap (₹Cr)
761
Face Value (₹)
10
P/E Ratio
2.56
Dividend Yield
N/A
Investment Returns
1 Year
-6%
3 Years
44.5%
5 Years
42.7%
10 Years
172.1%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 95.48 | Bearish |
| 10-DMA | 96.05 | Bearish |
| 20-DMA | 98.27 | Bearish |
| 50-DMA | 100.61 | Bearish |
| 100-DMA | 101.98 | Bearish |
| 200-DMA | 96.21 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 21 | 18 | 18 | 18 | 18 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 21 | 18 | 18 | 18 | 18 |
| Public Investors | 43759 | 28691 | 28099 | 28734 | 28865 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 2.56.
- 3Y Stock Price CAGR of the stock is 13.2.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹620 Million.
- The company generated revenue of ₹5617 Million in the previous financial year.
Ind-Swift Laboratories Ltd.
93.18-1.6 (-1.7%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 895186.9
No. of Shares: 9607 (Approx)
Performance:-10.5%
P/L: ₹-104813.1
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
